Insider · CIK 0001581754
Tananbaum James B.
Reports to the SEC for 13 companies · THOUSAND OAKS, CA
Transactions
50
Companies
13
Filings
3
CIK
0001581754
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.P Purchase | +$2.52M |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc.C Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series A-2 Convertible StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series A-2 Convertible Preferred StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series A-2 Convertible Preferred StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-08-10 | LTGOLatigo Biotherapeutics, Inc. · Convertible Promissory NoteC Conversion | — |
| 2026-04-01 | ALMSALUMIS INC.J Other | — |
| 2026-04-01 | ALMSALUMIS INC.J Other | — |
| 2026-04-01 | ALMSALUMIS INC.J Other | — |
| 2026-04-01 | ALMSALUMIS INC.J Other | — |
| 2026-01-08 | ALMSALUMIS INC.P Purchase | +$2M |
| 2026-01-08 | ALMSALUMIS INC.P Purchase | +$5M |
| 2025-11-21 | ALMSALUMIS INC.P Purchase | +$533K |
| 2025-11-19 | ALMSALUMIS INC.P Purchase | +$1.25M |
| 2025-11-18 | ALMSALUMIS INC.P Purchase | +$727K |
| 2025-11-17 | ALMSALUMIS INC.P Purchase | +$280K |
| 2025-11-17 | ALMSALUMIS INC.P Purchase | +$839K |
| 2025-05-06 | ALMSALUMIS INC.P Purchase | +$86.8K |
| 2025-05-02 | ALMSALUMIS INC.P Purchase | +$116K |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.P Purchase | +$5M |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.C Conversion | — |
| 2024-07-01 | ALMSALUMIS INC.P Purchase | +$35M |
| 2024-07-01 | ALMSALUMIS INC. · Series Seed Redeemable Convertible Preferred StockC Conversion | — |
| 2024-07-01 | ALMSALUMIS INC. · Series Seed Redeemable Convertible Preferred StockC Conversion | — |
| 2024-07-01 | ALMSALUMIS INC. · Series A Redeemable Convertible Preferred StockC Conversion | — |
| 2024-07-01 | ALMSALUMIS INC. · Series A Redeemable Convertible Preferred StockC Conversion | — |
| 2024-07-01 | ALMSALUMIS INC. · Series B-1 Redeemable Convertible Preferred StockC Conversion | — |
Recent filings
- 4Tananbaum James B.0001581754-26-000006SEC(opens sec.gov)
- 4Tananbaum James B.0001104659-26-039609SEC(opens sec.gov)
- 4Tananbaum James B.0001104659-26-003016SEC(opens sec.gov)
Companies
- 10x Genomics, Inc.10% OwnerTXG
- Aclaris Therapeutics, Inc.10% OwnerACRS
- AERIE PHARMACEUTICALS INC10% Owner
- Aimmune Therapeutics, Inc.10% Owner
- ALUMIS INC.Director, 10% OwnerALMS
- AMBIT BIOSCIENCES CORP10% Owner
- Disc Medicine, Inc.Director, 10% OwnerIRON
- Intellia Therapeutics, Inc.10% OwnerNTLA
- Kinnate Biopharma Inc.Director, 10% Owner
- Latigo Biotherapeutics, Inc.Director, 10% OwnerLTGO
- PARDES BIOSCIENCES, INC.Director, President and CEO, 10% Owner
- Quantum-Si IncDirectorQSI
- Theseus Pharmaceuticals, Inc.10% Owner
Address
C/O LATIGO BIOTHERAPEUTICS, INC. 1300 RANCHO CONEJO BLVD., SUITE 305
THOUSAND OAKS, CA, 91320